Marginal Zone Lymphoma Clinical Trials in Miami, Florida
7 recruitingMiami, Florida
Showing 1–7 of 7 trials
Recruiting
Phase 1
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Diffuse Large B-Cell Lymphoma (DLBCL)Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)+6 more
Nurix Therapeutics, Inc.572 enrolled62 locationsNCT05131022
Recruiting
Phase 1Phase 2
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma+6 more
BeOne Medicines645 enrolled130 locationsNCT05006716
Recruiting
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
Nodal Marginal Zone Lymphoma
International Extranodal Lymphoma Study Group (IELSG)300 enrolled36 locationsNCT05700149
Recruiting
Phase 2
Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma
Extranodal Marginal Zone Lymphoma
Izidore Lossos, MD35 enrolled1 locationNCT06569680
Recruiting
Phase 2
Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)
Marginal Zone LymphomaSplenic Marginal Zone LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+1 more
Izidore Lossos, MD25 enrolled1 locationNCT06796998
Recruiting
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Breast CancerOvarian CancerEndometrial Cancer+40 more
Massive Bio, Inc.50,000 enrolled68 locationsNCT03452774
Recruiting
Phase 2
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
Marginal Zone Lymphoma
University of Miami50 enrolled4 locationsNCT05296070